Antibodies News and Research

RSS

Measles vaccine more likely to be completely ineffective in children born by C-section

A study by the University of Cambridge, UK, and Fudan University, China, has found that a single dose of the measles jab is up to 2.6 times more likely to be completely ineffective in children born by C-section, compared to those born naturally.

13 May 2024

FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer

On April 29th, 2024, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor (TF) for the treatment of patients with recurrent or metastatic cervical cancer who have progressed on or after chemotherapy. This marks a significant advancement in the therapeutic landscape for cervical cancer, highlighting the potential of antibody-drug conjugates (ADCs) in oncology.

10 May 2024

Breakthrough vaccine strategy guides the immune system to generate HIV neutralizing antibodies

A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.

9 May 2024

Longitudinal antibody changes key to identifying peanut allergy resolution in kids

Australian researchers have discovered how changes in antibody levels over time can predict which children are likely to outgrow their peanut allergy.

9 May 2024

Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants

Researchers developed bispecific antibodies targeting both the N-terminal and receptor binding domains of SARS-CoV-2, demonstrating significant neutralization across various Omicron variants, suggesting potential for new COVID-19 treatments.

9 May 2024

Researchers enhance CAR-T cells to target solid tumors

Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors-;an advance that could transform cancer treatment.

8 May 2024

New Quartet nanocage vaccine shows promise against coronavirus variants

Researchers have developed a novel vaccination approach using Quartet nanocages that display receptor-binding domains (RBDs) from different sarbecoviruses, showing enhanced immune responses and potential protection against diverse coronavirus strains including SARS-CoV-2 and its variants.

8 May 2024

Enzyme implicated in telomere repair offers new avenues for cancer therapy

A new study led by University of Pittsburgh and UPMC Hillman Cancer Center researchers shows that an enzyme called PARP1 is involved in repair of telomeres, the lengths of DNA that protect the tips of chromosomes, and that impairing this process can lead to telomere shortening and genomic instability that can cause cancer.

7 May 2024

Sapio Sciences Unveils Enhanced Molecular Biology Toolkit

...

From Sapio Sciences 7 May 2024

New influenza vaccine strategies aim to enhance protection with T-cell responses

A recent review highlights the need for innovative influenza vaccines that combine T-cell and antibody responses to enhance protection across multiple strains and seasons.

6 May 2024

Novel vaccine approach targets AML and other blood cancers

Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft marrow of the bones, typically attacking cells that would otherwise form the key component of the body's immunodefense system, white blood cells.

3 May 2024

Bird flu is bad for poultry and dairy cows. It’s not a dire threat for most of us — yet.

Headlines are flying after the Department of Agriculture confirmed that the H5N1 bird flu virus has infected dairy cows around the country.

3 May 2024

New vaccine approach shows promise in targeting less variable region of influenza virus

Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable.

2 May 2024

Researchers unveil unique autoantibody profiles in rheumatoid arthritis patients

Patients with rheumatoid arthritis (RA) all have a unique and diverse set of antibodies that are involved in the development of the disease.

2 May 2024

A gut bacteria could hold the key to universal blood, revolutionizing transfusion medicine

Study found that exoglycosidases from Akkermansia muciniphila effectively target blood group antigens, potentially converting A and B blood types to ABO-universal blood.

1 May 2024

Bio-Rad launches three StarBright Red Dyes and expands range of antibody markers conjugated to StarBright Violet Dyes to enhance immunology research

...

From Bio-Rad Laboratories 1 May 2024

Avian flu crosses species, infecting cats and cattle in Texas and Kansas

A study in the CDC's Emerging Infectious Disease Journal reports the spread of H5N1 avian influenza among cats and dairy cattle in Texas and Kansas, showing systemic illness in cattle and significant fatalities in cats exposed to the virus through infected milk.

1 May 2024

Antibodies News and Research

Measles vaccine more likely to be completely ineffective in children born by C-section

FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer

Breakthrough vaccine strategy guides the immune system to generate HIV neutralizing antibodies

Longitudinal antibody changes key to identifying peanut allergy resolution in kids

Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants

Researchers enhance CAR-T cells to target solid tumors

New Quartet nanocage vaccine shows promise against coronavirus variants

Enzyme implicated in telomere repair offers new avenues for cancer therapy

Sapio Sciences Unveils Enhanced Molecular Biology Toolkit

New influenza vaccine strategies aim to enhance protection with T-cell responses

Novel vaccine approach targets AML and other blood cancers

Bird flu is bad for poultry and dairy cows. It’s not a dire threat for most of us — yet.

New vaccine approach shows promise in targeting less variable region of influenza virus

Researchers unveil unique autoantibody profiles in rheumatoid arthritis patients

A gut bacteria could hold the key to universal blood, revolutionizing transfusion medicine

Bio-Rad launches three StarBright Red Dyes and expands range of antibody markers conjugated to StarBright Violet Dyes to enhance immunology research

Avian flu crosses species, infecting cats and cattle in Texas and Kansas

New monoclonal antibody vaccine slashes malaria risk in children

U of T researchers develop new approach for controlling neuron generation in Parkinson's disease

Updated vaccine provides strong immune response against previous and emerging SARS-CoV-2 variants

Immunology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News